4D Molecular Therapeutics, Inc. · NASDAQ:FDMT

4D Molecular Therapeutics, Inc. shareholders

As of Sep 30, 2026, 160 institutions reported holding 4D Molecular Therapeutics, Inc. Largest: Janus Henderson, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of 4D Molecular Therapeutics, Inc.ChangeFiled
Janus Henderson5.73Mfirst reportNov 16, 2026
Ra Capital Management, L.P.5.05Mno changeNov 16, 2026
BlackRock4.72M+179KNov 13, 2026
Goldman Sachs3.93M−328KNov 16, 2026
Vanguard3.05M+80,557Nov 13, 2026
Novo Holdings A/S3M−249KNov 16, 2026
Bvf Inc2.88Mno changeNov 16, 2026
State Street2.47M−442KNov 12, 2026
T. Rowe Price2.32M−246KNov 16, 2026
Adage Capital Partners Gp, L.L.C.2.29M+40,000Nov 16, 2026

4D Molecular Therapeutics, Inc. insider trades